Septerna Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Septerna Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
South SAN Francisco
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SEPN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001984086
EIN
84-3891440

Board of directors

Follow this board

Chief executives

Jeffrey Finer · CEO and President
Since October 2024
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

1,000% a year in revenue

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Director election results

Annual meeting of June 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 35 other boards. 35 are in the same sector.

Network of Septerna Inc.'s board connections Bicara Therapeutics Inc. Bicara Therapeutics In... Janux Therapeutics Inc. Janux Therapeutics Inc... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Parabilis Medicines Inc. Parabilis Medicines In... Tyra Biosciences Inc. Tyra Biosciences Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bambusa Therapeutics Inc. Bambusa Therapeutics I... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Climb Bio Inc. Climb Bio Inc. Evommune Inc. Evommune Inc. Freenome Inc. Freenome Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Jade Biosciences Inc. Jade Biosciences Inc. Abraham Bassan Abraham Bassan Jake Simson Jake Simson Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Septerna Inc.
Shared director Other board Same sector +19 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$76,141,460
28 sales by 5 insiders
Date Insider Transaction Shares Price Value
Oct 15, 2026 Bhatt Elizabeth Officer (President and COO) Option exercise +4,000 $6.81 $27,240
Oct 15, 2026 Bhatt Elizabeth Officer (President and COO) Open-market sale −1,094 $36.87 $40,337
Oct 15, 2026 Bhatt Elizabeth Officer (President and COO) Open-market sale −2,906 $37.61 $109,307
Sep 1, 2026 Long Daniel D. Officer (SVP, Drug Discovery) Option exercise +3,333 $2.76 $9,199
Sep 1, 2026 Long Daniel D. Officer (SVP, Drug Discovery) Open-market sale −3,333 $37.83 $126,087
Aug 12, 2026 Rajeev M. Shah Director, 10% owner Open-market sale −746,500 $42.50 $31,726,250
Aug 12, 2026 Third Rock Ventures GP VI, L.P. 10% owner Open-market sale +147,059 $50.27 $7,392,656
Aug 12, 2026 Rajeev M. Shah Director, 10% owner Open-market sale −746,500 $42.50 $31,726,250
Aug 12, 2026 Third Rock Ventures GP VI, L.P. 10% owner Open-market sale +141 $51.08 $7,202
Aug 11, 2026 Bhatt Elizabeth Officer (President and COO) Option exercise +18,681 $6.81 $127,218
Aug 11, 2026 Bhatt Elizabeth Officer (President and COO) Option exercise +6,319 $2.76 $17,440
Aug 11, 2026 Bhatt Elizabeth Officer (President and COO) Open-market sale −25,000 $44.00 $1,100,000
Aug 3, 2026 Long Daniel D. Officer (SVP, Drug Discovery) Option exercise +1,816 $2.76 $5,012
Aug 3, 2026 Long Daniel D. Officer (SVP, Drug Discovery) Option exercise +1,518 $2.76 $4,190
Aug 3, 2026 Long Daniel D. Officer (SVP, Drug Discovery) Open-market sale −1,000 $33.98 $33,980

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States

Questions about Septerna Inc.

Who is the CEO of Septerna Inc.?

Jeffrey Finer has been Septerna Inc.'s CEO and President since October 2024.

How many directors are on Septerna Inc.'s board?

Septerna Inc.'s board has 10 directors: Abraham Bassan, Alan Ezekowitz, Bernard Coulie, Jake Simson, Jeffrey Finer, Jeffrey K. Tong, Keith Michael Gottesdiener, Peter Kolchinsky, Rajeev M. Shah and Shalini Sharp.

Are Septerna Inc. insiders buying or selling shares?

Over the last 12 months, Septerna Inc. insiders made no open-market purchases and sold $76.1 million of shares in 28 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Septerna Inc. connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="septerna-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.